BioCentury
ARTICLE | Financial News

Visterra withdraws IPO

February 17, 2017 4:46 PM UTC

On Feb. 10, anti-infectives company Visterra Inc. (Cambridge, Mass.) withdrew its proposed IPO on NASDAQ, citing market conditions. Leerink Partners, Stifel, Needham and Wedbush PacGrow were underwri...

BCIQ Company Profiles

Visterra Inc.